Close Menu
NEW YORK – Thermo Fisher Scientific said after the close of the market on Monday that it has priced an offering of $2.2 billion worth of senior notes.
 
The offering consists of $1.1 billion in senior notes with an interest rate of 4.133 percent due 2025 at the issue price of 100 percent of their principal amount; and $1.1 billion in senior notes with an interest rate of 4.97 percent due 2030 at the issue price of 100 percent of their principal amount.
 
The offering is expected to close on or about March 25, 2020, subject to customary closing condi

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.